Trials / Completed
CompletedNCT01707628
Response to Influenza Vaccination in Lymphoma Patients Treated With Rituximab
Response to Influenza Vaccination in Lymphoma Patients Treated With CHOP and Rituximab
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 98 (actual)
- Sponsor
- St. Antonius Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the number of responders to vaccination with the influenza virus vaccine at different time points after last dose of rituximab in patients with lymphoma. Secondly to study the immune-response to vaccination with influenza virus vaccine, after treatment with rituximab in relation to the reconstitution of immune-function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | influenza vaccination with influenza vaccine |
Timeline
- Start date
- 2012-10-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2012-10-16
- Last updated
- 2014-01-31
Locations
7 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01707628. Inclusion in this directory is not an endorsement.